Obstetric Considerations in the Management of Pregnancy in Kidney Transplant Recipients

Advances in Chronic Kidney Disease

Volumn 14, Issue 2, 2007, Pages 168-177

  del Mar Colon, Maria ^a   Hibbard, Judith U ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Hypertension; Immunosuppression; Preeclampsia; Pregnancy; Transplantation

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAMETHASONE; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CEFALEXIN; CERVICIDIL; CYCLOSPORIN; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; GANCICLOVIR; HYDRALAZINE; IMMUNOSUPPRESSIVE AGENT; IRON; LABETALOL; LEFLUNOMIDE; MAGNESIUM SULFATE; METHYLDOPA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITROFURANTOIN; PROGESTERONE; PROSTAGLANDIN E2; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG; VALACICLOVIR;

ACUTE GRAFT REJECTION; ARTICLE; BLOOD PRESSURE REGULATION; BREAST FEEDING; CESAREAN SECTION; CONTRACEPTION; CYTOMEGALOVIRUS INFECTION; DELIVERY; FEMALE; FETUS LUNG MATURITY; FETUS MALFORMATION; GRAFT FAILURE; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAUTERINE GROWTH RETARDATION; IRON THERAPY; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT; LABOR; LOADING DRUG DOSE; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; NOCICEPTION; OPPORTUNISTIC INFECTION; PATIENT COUNSELING; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PUERPERAL INFECTION; RECOMMENDED DRUG DOSE; REPRODUCTION; SEIZURE; TOXOPLASMOSIS; URINARY TRACT INFECTION; VAGINAL DELIVERY; VITAMIN SUPPLEMENTATION;

COUNSELING; FEMALE; GRAFT REJECTION; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; POSTPARTUM PERIOD; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; URINARY TRACT INFECTIONS;

EID: 33947533997     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2007.01.007     Document Type: Article

References (52)

1. McKay D.B., and Josephson M.A. Pregnancy in recipients of solid organ: Effects on mother and child. N Engl J Med 354 (2006) 1281-1293
2. Watnick S. Pregnancy and contraceptive counseling of women with chronic kidney disease and kidney transplants. Adv Chronic Kidney Dis 14 (2007) 126-131
3. Davidson J.M., and Lindheimer M.D. Renal disorders. In: Creasy R.K., Resnik R., and Iams J. (Eds). Maternal-Fetal Medicine: Principles and Practice. (ed 5) (2004), Saunders, Philadelphia, PA 901-924
4. Stugiss S.N., and Davidson J.M. Effect of pregnancy on long term function of renal allograft. Am J Kidney Dis 19 (1992) 167-172
5. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant 17 suppl (2002) 50-55
6. Stratta P., Canavese C., Giacchino F., et al. Pregnancy in kidney transplantation: Satisfactory outcomes and harsh realities. J Nephrol 16 (2003) 792-806
7. Lessan-Pezeschi M. Pregnancy after renal transplantation: Point to consider. Nephol Dial Transplant 17 (2002) 703-707
8. Miranda C.T.B.C., Melgrano C., Camara N.O., et al. Adverse effect of pregnancy on renal allograft function. Transplant Proc 34 (2002) 506-507
9. Josephson M.A., and McKay D.B. Considerations in the medical management of pregnancy in transplant recipients. Adv Chronic Kidney Dis 14 (2007) 156-167
10. Armenti V.T., McGrory C.H., Cater J.S., et al. Pregnancy outcomes in female renal transplant recipients. Transplant Rev (Orlando) 30 (1998) 1732-1743
11. McKay D.B., and Josephson M.A. Reproduction and transplantation: Report on the AST consensus conference on reproductive issues and transplantation. Am J Transplant 5 (2005) 1592-1599
12. Davison J.M. Pre-pregnancy care and counseling in chronic renal patients. Euro Clin Obstet Gynecol (2007) (in press)
13. Umans J.G. Medications during pregnancy: Antihypertensives and immunosuppressives. Adv Chronic Kid Dis 14 (2007) 191-205
14. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354 (2006) 2443-2451
15. LeRay C., Coulomb A., Elefant E., et al. Mycophenolate mofetil in pregnancy after renal transplantation: A case of major fetal malformations. Obstet Gynecol 102 (2004) 1091-1094
16. Armenti V.T., Moritz M.J., Cardonick E.M., et al. Immunosupression in pregnancy: Choices for infant and maternal health. Drugs 62 (2002) 2361-2375
17. Davidson J.M. The effect of pregnancy on kidney function in renal allograft recipients. Kidney Int 27 (1985) 74-79
18. Armenti V.T., Radomski J.S., Moritz M.J., et al. Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation. In: Cecka J.M., and Terasaki P.I. (Eds). Clinical Transplants (2004), UCLA Immunogenetics Center, Los Angeles, CA 103-114
19. First M.R., Combs C.A., Weiskittel P., et al. Lack of effect of pregnancy on renal allograft survival or function. Transplantation 59 (1995) 472-476
20. Armenti V.T., Ahlswede K.M., Ahlswede B.A., et al. National Transplantation Pregnancy Registry: Outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 57 (1994) 502-506
21. Radomski J.S., Ahlswede B.A., Jarrell B.E., et al. Outcomes of 500 pregnancies in 335 female kidney, liver, and heart transplant recipients. Transplant Proc 27 (1995) 1089-1090
22. Sibai B.M., Lindheimer M., Hauth J., et al., National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med 339 (1998) 667-671
23. Manning F.A., Harman C.R., Morrison I., et al. Fetal assessment based on fetal biophysical scoring: Experience in 19,221 high-risk pregnancies. Am J Obstet Gynecol 157 (1987) 880-884
24. Manning F.A., Harman C.R., Morrison I., et al. Fetal assessment based on fetal biophysical scoring. IV. An analysis of perinatal morbidity and mortality. Am J Obstet Gynecol 162 (1990) 703-709
25. Kingdom J.C.P., Burrell S.J., and Kaufman P. Pathology and clinical implications of abnormal umbilical artery Doppler waveforms. Ultrasound Obstet Gynecol 9 (1997) 271-286
26. Alfirevic Z., and Neilson J.P. Doppler ultrasound in high risk pregnancy: Systematic review with a meta-analysis. Am J Obstet Gynecol 172 (1995) 1379-1387
27. Streven H., Wide-Swensson D., Grubb A., et al. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancy. Br J Obstet Gynecol 110 (2003) 825-830
28. Akbari A., Lepage N., Keely E., et al. Cystatic-C and beta-trace proteinas markers of renal function in pregnancy. Br J Obstet Gynecol 112 (2005) 575-578
29. Morales J.M., Hernandez P.G., Andres A., et al. Uric acid handling, pregnancy and cyclosporine in renal transplant women. Nephron 56 (1990) 97-98
30. National Institute of Health Consensus Development Conference Statement: Effect of corticosteroids for fetal maturation on perinatal outcomes. Am J Obstet Gynecol 173 (1995) 246
31. Duley L., Farrel B., Spark P., et al. Do women with preeclampsia and their babies benefit from magnesium sulfate?. The Magpie Trial: A randomized, placebo-controlled trial. Lancet 359 (2002) 1877-1890
32. Schiffe E., Friedman S.A., and Sibai B.M. Conservative management of severe preeclampsia remote from term. Obstet Gynecol 84 (1994) 626-630
33. Morgan M.A., Berkowitz K.M., Thomas S.G., et al. Abruptio placentae perinatal outcome in normotensive and hypertensive patients. Am J Obstet Gynecol 170 (1994) 1595-1599
34. Kass E.H. The role of asymptomatic bacteruria in the pathogenesis of pyelonephritis. In: Quinn E.L., and Kass E.H. (Eds). Biology of Pyelonephritis (1960), Little, Brown, Boston, MA 399-412
35. Gibbs R.S., Sweet R.L., and Duff P. Maternal and fetal infectious disorders. In: Creasy R.K., and Resnik R. (Eds). Maternal Fetal Medicine Principles and Practice. (ed 5) (2004), Saunders, Philadelphia, PA 741-801
36. Armenti V.T., Moritz M.J., and Davison J.M. Medical management of the pregnant transplant recipient. Adv Renal Replacement Ther 5 (1998) 14
37. Crowe A.V., Rustom R., Gradden C., et al. Pregnancy does not adversely affect renal transplant function. Q J Med 92 (1999) 631-635
38. Galdo T., Gonzalez M., Espinoza N., et al. Impact of pregnancy on the function of transplanted kidneys. Transplant Proc 37 (2005) 1577-1579
39. Thompson B.C., Kingdon E.J., Tuck S.M., et al. Pregnancy in renal transplant recipients: The Royal Free Hospital experience. Q J Med 96 (2003) 837-844
40. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Eng J Med 348 (2003) 2379-2385
41. Armenti V.T., Ahlswede K.M., Ahlswede B.A., et al. Variables affecting birthweight and graft survival in 197 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 59 (1995) 476-479
42. Little M.A., Abraham K.A., Kavanagh J., et al. Pregnancy in Irish renal transplant recipients. I. The cyclosporine era. Ir J Med Sci 169 (2000) 19-21
43. Bernstein I., Gabbe S.G., and Reed K.L. Intrauterine growth restriction. In: Gabbe S.G., Niebyl J.R., and Simpson J.L. (Eds). Obstetrics: Normal and Problem Pregnancies. (ed 4) (2002), Churchill Livingstone, New York, NY 869-891
44. Resnick R., and Creasy R.K. Intrauterine growth restriction. In: Creasy R.K., Resnik R., and Iams J. (Eds). Maternal-Fetal Medicine: Principles and Practice. (ed 5) (2004), Saunders, Philadelphia, PA 495-512
45. Boppana S.B., Rivera L.B., Fowler K.B., et al. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 344 (2001) 1366-1371
46. Scott L.L., Sanchez P.J., Jackson G.L., et al. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 87 (1996) 69-73
47. Sheffield J.S., Hill J.B., Hollier L.M., et al. Valcyclovir prophylaxis to prevent recurrent herpes at delivery: A randomized clinical trial. Obstet Gynecol 108 (2006) 141-147
48. Center for Disease Control. Sexually transmitted diseases treatment guidelines. Morb Mort Wkly Rev 51 RR-6 (2002)
49. American College of Obstetrics and Gynecology. Gestation diabetes mellitus. ACOG Practice Bulletin No. 30. Obstet Gynecol 98 (2001) 525-538
50. Ghandour F.Z., Knauss T.C., and Hricik D.E. Immunossupressive drugs in pregnancy. Adv Renal Replace Ther 5 (1998) 31-37
51. Moretti M.E., Sgro M., Johnson D.W., et al. Cyclosporin excretion into breast milk. Transplantation 75 (2003) 2144-2146
52. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatr 83 (1994) 137-150